The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 6, 2013, Pages 620-624

  Verma, Jonathan ^a   Jonasch, Eric ^a   Allen, Pamela K ^a   Weinberg, Jeffrey S ^a   Tannir, Nizar ^a   Chang, Eric L ^a   Mahajan, Anita ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Brain metastasis; Renal cell carcinoma; Resection; Stereotactic radiosurgery; Tyrosine kinase inhibitors

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84892595963     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31825d59db     Document Type: Article

References (20)

1. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol, 2004;22:4991-5004.
2. Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-Targeted therapy in renal cell carcinoma. J Clin Oncol. 2005;23:1028-1043.
3. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002;20:4368-4380.
4. Saitoh H, Shimbo T, Tasaka T, et al. Brain metastasisof renal adenocarcinoma. Tokai J Exp Clin Med. 1982;7:337-343.
5. Jemal A, Seigel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
6. Massard C, Zonierek J, Gross-Goupil M, et al. Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Ann Oncol. 2010;21:1027-1031.
7. Verma J, Jonasch E, Allen P, et al. Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma. Cancer. 2011;117:4958-4965.
8. Walid MS, Johnston KW. Successful treatment of a brainmetastasized renal cell carcinoma. Ger Med Sci: GMS e-journal. 2009;7. Doc 28.
9. Helgason HH, Mallo HA, Droogendijk H, et al. Brain metastases in patients with renal cell cancer receiving new targeted treatment. J Clin Oncol. 2008;26:152-154.
10. Vogl UM, Bojic M, Lamm W, et al. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma. BMC Cancer. 2010;10:480-490.
11. Motzer RJ, Bacik J, Murphy BA, et al. Interferon-Alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20:289-296.
12. StataCorp. Stata: Release 11. Statistical Software. College Station, TX: StataCorp LP; 2009.
13. Nieder C, Niewald M, Schnabel K. Treatment of brain metastases from hypernephroma. Urol Int. 1996;57:17-20.
14. Gay PC, Litchy WJ, Cascino TL. Brain metastasis in hypernephroma. J Neurooncol. 1987;5:51-56.
15. Wronski M, Maor MH, Davis BJ, et al. External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 1997;37:753-759.
16. Sheehan JP, Sun MH, Kondziolka D, et al. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: longterm outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg. 2003;98:342-349.
17. Ikushima H, Tokuuye K, Sumi M, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:1389-1393.
18. Amendola BE, Wolf AL, Coy SR, et al. Brain metastases in renal cell carcinoma: management with gamma knife radiosurgery. Cancer J. 2000;6:372-376.
19. Halperin EC, Harisiadis L. The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer. 1983;51:614-617.
20. Staehler M, Aseke N, Nuhn P, et al. Simultaneous anti-Angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int. 2010;108:673-678.